Rockwell Medical (RMTI) Restructuring Costs (2018 - 2019)

Rockwell Medical (RMTI) reported Restructuring Costs of -$30000.0 for Q4 2019, down 106.98% quarter-over-quarter from $430000.0 in Q2 2019.

Rockwell Medical (RMTI) Restructuring Costs (2018 - 2019) Analysis & Trends

Rockwell Medical has reported Restructuring Costs for 2 years, with the latest figure at -$30000.0 in Q4 2019.

For the quarter ending Q4 2019, Restructuring Costs changed N/A year-over-year to -$30000.0; the trailing twelve-month figure through Dec 2020 stood at -$30000.0 (down 107.5% YoY), and the FY2019 full-year result was $400000.0, down 61.17% from the prior year.
Restructuring Costs for Q4 2019 stood at -$30000.0, down from $430000.0 in the prior quarter.
The five-year high for Restructuring Costs was $1.0 million in Q2 2018, with the low at -$30000.0 in Q4 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	38.34 Bn	34.60 Bn	1.97 Bn
2	Zoetis	33.27 Bn	31.33 Bn	1.62 Bn
3	United Therapeutics	23.75 Bn	21.60 Bn	648.10 Mn
4	Aurora Cannabis	17.11 Bn	17.03 Bn	33.43 Mn
5	Neurocrine Biosciences	16.37 Bn	15.05 Bn	800.70 Mn
6	Elanco Animal Health	11.78 Bn	11.35 Bn	785.00 Mn
7	Alkermes	7.05 Bn	6.54 Bn	-116.06 Mn
8	Lantheus Holdings	6.49 Bn	5.99 Bn	230.92 Mn
9	Hims & Hers Health	6.19 Bn	5.44 Bn	396.79 Mn
10	Rockwell Medical	26.01 Mn	2.12 Mn	2.90 Mn

Download Data